Frequency of BRCA1 mutation 5382insC in German breast cancer patients.
about
Founder populations and their uses for breast cancer genetics.Ashkenazi Jews and breast cancer: the consequences of linking ethnic identity to genetic diseaseHigh proportion of recurrent germline mutations in the BRCA1 gene in breast and ovarian cancer patients from the Prague areaBRCA genetic screening in Middle Eastern and North African: mutational spectrum and founder BRCA1 mutation (c.798_799delTT) in North AfricanMutation analysis of the MDM4 gene in German breast cancer patientsRapid detection of carriers with BRCA1 and BRCA2 mutations using high resolution melting analysis.Prevalence of founder BRCA1 and BRCA2 mutations among breast and ovarian cancer patients in Hungary.Mutation analysis of BRCA1, BRCA2, PALB2 and BRD7 in a hospital-based series of German patients with triple-negative breast cancer.Founder and Recurrent Mutations in BRCA1 and BRCA2 Genes in Latin American Countries: State of the Art and Literature Review.On the origin and diffusion of BRCA1 c.5266dupC (5382insC) in European populations.Hereditary breast cancer in Middle Eastern and North African (MENA) populations: identification of novel, recurrent and founder BRCA1 mutations in the Tunisian populationPrevalence of the BRCA1 founder mutation c.5266dupin Brazilian individuals at-risk for the hereditary breast and ovarian cancer syndrome.Validation of three BRCA1/2 mutation-carrier probability models Myriad, BRCAPRO and BOADICEA in a population-based series of 183 German families.Founder BRCA1/2 mutations in the Europe: implications for hereditary breast-ovarian cancer prevention and control.Contribution of BRCA1 germ-line mutations to breast cancer in Greece: a hospital-based study of 987 unselected breast cancer cases.Mutation analysis of the ERCC4/FANCQ gene in hereditary breast cancer.Mutation analysis of the SLX4/FANCP gene in hereditary breast cancer.Frequency of 5382insC mutation of BRCA1 gene among breast cancer patients: an experience from Eastern India.High frequency of recurrent mutations in BRCA1 and BRCA2 genes in Polish families with breast and ovarian cancer.Addition of triple negativity of breast cancer as an indicator for germline mutations in predisposing genes increases sensitivity of clinical selection criteria
P2860
Q24544179-0B26C864-2C3B-4D42-8305-96371A054618Q24675652-F9B1053D-1093-422B-A1DC-11AB512BAD69Q24813558-C6D4FDE1-80A8-4F4D-A347-77C89713B45CQ27002334-E8D3F0C0-3627-4A20-ABE1-279E27FAB54AQ33320072-2E5B1583-E303-4391-A57A-F5001A176B4CQ33321039-F659F6F9-81F4-4F77-B1A6-140708CA8F2DQ33900686-23D820F2-6663-48C1-A4C8-C737D680F2BEQ34460831-F511548E-1EA7-404E-830B-82348B536C85Q34530426-50552A79-4137-4D22-A410-11B8A5110102Q34705352-06FC7A83-DA40-43C1-91D0-68D4069D56FEQ35645650-AFD54F0E-E2DD-44D2-B4C7-71D24B312AF8Q35856408-663C739E-6C23-4200-9458-BAAAC4E733EAQ36001486-BE01C6E7-3336-40EA-86C5-97E9AA0BED3CQ36117690-B9F9C4EB-E1A8-492F-96BF-AE1CC7472860Q37269654-98EF1FF9-B357-4197-9AE5-03A0E0AC684AQ37499453-BCEBBE5B-C892-4131-B453-020F4ACC691AQ51431905-617605B2-BA6E-402B-AE36-87F31CFA5635Q54279806-FB0A5C2F-2B73-4470-8FE0-78FBC117EBB7Q55034444-22D01CC6-97FF-4B79-9CD0-0D1DA066449CQ58695244-7FC7D7D6-FA93-465E-9DF1-EB3C5D171338
P2860
Frequency of BRCA1 mutation 5382insC in German breast cancer patients.
description
1999 nî lūn-bûn
@nan
1999 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի մարտին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Frequency of BRCA1 mutation 5382insC in German breast cancer patients.
@ast
Frequency of BRCA1 mutation 5382insC in German breast cancer patients.
@en
type
label
Frequency of BRCA1 mutation 5382insC in German breast cancer patients.
@ast
Frequency of BRCA1 mutation 5382insC in German breast cancer patients.
@en
prefLabel
Frequency of BRCA1 mutation 5382insC in German breast cancer patients.
@ast
Frequency of BRCA1 mutation 5382insC in German breast cancer patients.
@en
P2093
P50
P356
P1433
P1476
Frequency of BRCA1 mutation 5382insC in German breast cancer patients
@en
P2093
Burgemeister R
Hofferbert S
Karstens JH
P304
P356
10.1006/GYNO.1998.5270
P407
P577
1999-03-01T00:00:00Z